Universitätsklinikum Tübingen

Hospital


Location: Tübingen, Germany (DE) DE

ISNI: 0000000101968249

ROR: https://ror.org/00pjgxh97

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Lang wirksames Wachstumshormon – eine neue Therapieoption für Kinder mit Wachstumshormonmangel: Status 2024 (2024) Dörr HG, Bettendorf M, Wölfle J, Saenger P, Ranke MB Journal article MoReLife – real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients (2024) Jilg S, Schwaab J, Sockel K, Crodel CC, Brückl V, Stegelmann F, Jentzsch M, et al. Journal article Vaccine-associated axillary lymphadenopathy with a focus on COVID-19 vaccines Impfassoziierte axillare Lymphadenopathie mit Fokus auf COVID-19-Impfstoffe (2024) Wilpert C, Wenkel E, Baltzer PAT, Fallenberg EM, Preibsch H, Sauer ST, Siegmann-Luz K, et al. Journal article Transcriptomic analysis of intestine following administration of a transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in celiac disease (2024) Dotsenko V, Tewes B, Hils M, Pasternack R, Isola J, Taavela J, Popp A, et al. Journal article Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events (2024) Koch E, Petzold A, Dippel E, Erdmann M, Gesierich A, Gutzmer R, Hassel JC, et al. Journal article Late-onset Krabbe disease presenting as spastic paraplegia – implications of GCase and CTSB/D (2024) Mächtel R, Dobert J, Hehr U, Weiß A, Kettwig M, Laugwitz L, Groeschel S, et al. Journal article Update Breast Cancer 2024 Part 1 - Expert Opinion on Advanced Breast Cancer (2024) Würstlein R, Kolberg HC, Hartkopf AD, Fehm TN, Welslau M, Schütz F, Fasching P, et al. Journal article An Empirical Survey on the Adaption of Neoadjuvant Chemotherapy in Bladder Cancer (2024) Reike MJ, Reicherz A, Tully KH, Bahlburg H, Maas M, Bach P, Klümper N, et al. Journal article Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma. (2024) Albrecht LJ, Dimitriou F, Grover P, Hassel JC, Erdmann M, Forschner A, Johnson DB, et al. Journal article Joint recommendations on cost calculation and estimation in paediatric clinical trials (2024) Ahne G, Nagel J, Franz AR, Neubert A, Schachtrup K, Helms S, Klammt S, Schwab M Journal article, Review article